Clinical Trial Update: Boosted Atazanavir and Truvada Given Once-Daily - BATON Study [Phase 4]

View source ↗

Summary

This Phase 4 BATON trial assessed once-daily boosted atazanavir in combination with Truvada for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED